Concepedia

Koert Gerzon

KG

39

Publications

1.9K

Citations

25

H-Index

1947

Active since

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

University of Nevada, Reno

Université de Sherbrooke

Koert Gerzon is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1947–1997

39

Publications

39

Erythromycin. I. Properties and Degradation Studies<sup>1</sup>

Edwin H. Flynn, Max V. Sigal, Paul F. Wiley et al. · Journal of the American Chemical Society · 1954 · 204 citations

, , +20

Erythromycin. X.<sup>1</sup> Structure of Erythromycin

Paul F. Wiley, Koert Gerzon, Edwin H. Flynn et al. · Journal of the American Chemical Society · 1957 · 151 citations

, , +16

The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas

Koert Gerzon, Eriks V. Krumkalns, Richard L. Brindle et al. · Journal of Medicinal Chemistry · 1963 · 140 citations

, , +15

Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfate

Charles J. Barnett, George J. Cullinan, Koert Gerzon et al. · Journal of Medicinal Chemistry · 1978 · 138 citations

BIOCHEMISTRY AND BIOLOGICAL EFFECTS OF THE PYRAZOFURINS<sup>*</sup> (PYRAZOMYCINS): INITIAL CLINICAL TRIAL

Gerald E. Gutowski, Martin Sweeney, Donald C. DeLong et al. · Annals of the New York Academy of Sciences · 1975 · 109 citations

, , +6

Rows per page

1–5 of 39